Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
313.64
+5.59 (1.81%)
At close: Sep 5, 2025, 4:00 PM
314.00
+0.36 (0.11%)
After-hours: Sep 5, 2025, 7:56 PM EDT
Elevance Health Market Cap
Elevance Health has a market cap or net worth of $70.62 billion as of September 5, 2025. Its market cap has decreased by -43.91% in one year.
Market Cap
70.62B
Enterprise Value
92.25B
1-Year Change
-43.91%
Ranking
Category
Stock Price
$313.64
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from $4.17B to $70.62B, an increase of 1,595.47%. That is a compound annual growth rate of 12.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 70.62B | -17.45% |
Dec 31, 2024 | 85.56B | -22.78% |
Dec 29, 2023 | 110.80B | -9.56% |
Dec 30, 2022 | 122.51B | 8.89% |
Dec 31, 2021 | 112.51B | 40.89% |
Dec 31, 2020 | 79.86B | 4.27% |
Dec 31, 2019 | 76.58B | 12.74% |
Dec 31, 2018 | 67.93B | 17.57% |
Dec 29, 2017 | 57.77B | 52.54% |
Dec 30, 2016 | 37.87B | 4.04% |
Dec 31, 2015 | 36.40B | 7.31% |
Dec 31, 2014 | 33.92B | 24.29% |
Dec 31, 2013 | 27.29B | 47.54% |
Dec 31, 2012 | 18.50B | -19.73% |
Dec 30, 2011 | 23.05B | 2.97% |
Dec 31, 2010 | 22.38B | -16.23% |
Dec 31, 2009 | 26.72B | 24.58% |
Dec 31, 2008 | 21.45B | -57.21% |
Dec 31, 2007 | 50.12B | 2.73% |
Dec 29, 2006 | 48.79B | -0.77% |
Dec 30, 2005 | 49.17B | 208.05% |
Dec 31, 2004 | 15.96B | 53.90% |
Dec 31, 2003 | 10.37B | 16.57% |
Dec 31, 2002 | 8.90B | 74.35% |
Dec 31, 2001 | 5.10B | 22.50% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 652.84B |
Johnson & Johnson | 429.72B |
AbbVie | 375.50B |
UnitedHealth Group | 285.64B |
AstraZeneca | 253.68B |
Novartis AG | 252.55B |
Novo Nordisk | 244.67B |
Abbott Laboratories | 231.38B |